Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Foundation Medicine (FMI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Foundation Medicine and Collaborators to Present New Data at the American Society of Hematology (ASH) Annual Meeting that Supports Use of FoundationOne(R)Heme to Advance Personalized Medicine in Blood Cancers

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that new data generated with FoundationOne(R)Heme, its comprehensive genomic profiling (CGP) assay for hematologic malignancies...

FMI : 65.45 (-2.46%)
Company News For Dec 5, 2017

Companies In The News are: AET,BGC,CVS,FMI,EXAC

AET : 182.36 (-0.20%)
CVS : 73.00 (-0.12%)
FMI : 65.45 (-2.46%)
EXAC : 50.20 (-0.20%)
BGC : 29.75 (unch)
FDA Approves Foundation Medicine's FoundationOne CDx(TM), the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics

--The Centers for Medicare and Medicaid Services issued a preliminary National Coverage Determination (NCD) for FoundationOne CDx, improving access to molecular information for personalized healthcare--...

FMI : 65.45 (-2.46%)
Caris Life Sciences Files Patent Infringement Suit against Foundation Medicine, Inc.

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that the Company has filed a patent infringement suit against Foundation...

FMI : 65.45 (-2.46%)
Options Traders Expect Huge Moves in Foundation Medicine (FMI) Stock

Investors in Foundation Medicine (FMI) need to pay close attention to the stock based on moves in the options market lately.

FMI : 65.45 (-2.46%)
Foundation Medicine Announces 2017 Third Quarter Results and Recent Highlights

Foundation Medicine, Inc. (NASDAQ: FMI) today reported financial and operating results for its third quarter ended September 30, 2017. Results and business highlights for the quarter...

FMI : 65.45 (-2.46%)
Foundation Medicine to Present Validation for FoundationOne CDx(TM), a Comprehensive Genomic Profiling Assay for Advancing Precision Cancer Care

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the company will present validation data for FoundationOne CDx, its comprehensive genomic profiling assay, at the International...

FMI : 65.45 (-2.46%)
Foundation Medicine Announces Timing for Third Quarter 2017 Financial Results and Conference Call

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's third quarter ended September 30, 2017 will be released on Wednesday, November 1, 2017....

FMI : 65.45 (-2.46%)
Foundation Medicine Appoints Tom Civik as Chief Commercial Officer

Foundation Medicine, Inc. (NASDAQ:FMI) today announced the appointment of Tom Civik to the role of chief commercial officer. Mr. Civik brings to Foundation Medicine more than two decades...

FMI : 65.45 (-2.46%)
Lifshitz & Miller LLP Announces Investigation of Foundation Medicine, Inc., Health Insurance Innovations, Inc., Juno Therapeutics, Inc., LendingClub Corporation, MiMedx Group, Inc., Ooma, Inc. and SCANA Corporation

Foundation Medicine, Inc. (FMI)

OOMA : 11.25 (+1.35%)
MDXG : 11.75 (-0.17%)
FMI : 65.45 (-2.46%)
SCG : 42.90 (-6.29%)
LC : 3.48 (-0.85%)
HIIQ : 22.60 (-0.88%)
JUNO : 51.81 (-11.66%)
Lifshitz & Miller LLP Announces Investigation of Foundation Medicine, Inc., Health Insurance Innovations, Inc., Juno Therapeutics, Inc., LendingClub Corporation, MiMedx Group, Inc., Ooma, Inc. and SCANA Corporation

NEW YORK , Oct. 3, 2017 /PRNewswire/ --

OOMA : 11.25 (+1.35%)
MDXG : 11.75 (-0.17%)
FMI : 65.45 (-2.46%)
SCG : 42.90 (-6.29%)
LC : 3.48 (-0.85%)
HIIQ : 22.60 (-0.88%)
JUNO : 51.81 (-11.66%)
Foundation Medicine Receives Approval from the State of New York for its FoundationACT Liquid Biopsy Assay

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that it received approval from the New York State (NYS) Clinical Laboratory Evaluation Program (CLEP) for its FoundationACT(R)...

FMI : 65.45 (-2.46%)
FOUNDATION MEDICINE 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors of Deadline in Class Action Lawsuit Against Foundation Medicine, Inc. - (FMI)

ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until September 26, 2017 to file lead plaintiff applications in a securities class action lawsuit...

FMI : 65.45 (-2.46%)
DEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 25, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Foundation Medicine, Inc. ("Foundation" or the "Company") (NASDAQ:...

FMI : 65.45 (-2.46%)
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Foundation Medicine, Inc. (FMI)

Glancy Prongay & Murray LLP ("GPM") reminds investors of the September 26, 2017 deadline in the class action lawsuit filed on behalf of investors who purchased Foundation Medicine,...

FMI : 65.45 (-2.46%)
DEADLINE TOMORROW: Khang & Khang LLP Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Encourages Investors with Losses to Contact the Firm

Khang & Khang LLP (the "Firm") announces a securities class action lawsuit against Foundation Medicine, Inc. ("Foundation" or the "Company") (Nasdaq:FMI). Investors who purchased or otherwise acquired...

FMI : 65.45 (-2.46%)
DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Foundation Medicine, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 26, 2017 - FMI

NEW YORK, NY / ACCESSWIRE / September 25, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

FMI : 65.45 (-2.46%)
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Foundation Medicine, Inc. (FMI) & Lead Plaintiff Deadline: September 26, 2017

NEW YORK, NY / ACCESSWIRE / September 25, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Foundation Medicine, Inc. ("Foundation" or the...

FMI : 65.45 (-2.46%)
FOUNDATION MEDICINE 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Foundation Medicine, Inc. - (FMI)

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until September...

FMI : 65.45 (-2.46%)
Reminder Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Looming Deadline in the Class Action Lawsuit Against Foundation Medicine, Inc. (FMI)

Law Offices of Howard G. Smith reminds investors of the September 26, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Foundation...

FMI : 65.45 (-2.46%)

Van Meerten Stock Picks

5 Great Large Caps
Today I wanted to find 5 Large Caps that still had some upside potential.
ALL -0.50 , AMP -0.85 , LB +0.23 , AXP +0.27 , AKAM +0.25
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH18 +0.09%) this morning are up +0.08% and European stocks are down -0.12% . Most global stocks markets moved higher ahead of central bank meetings this week from the Fed, ECB and BOE. U.S.... Read More

Chart of the Day

Chart of the Day

Viking Therapeutics (VKTX) is the Barchart Chart of the Day.  The biopharmaceutical company has a Trend Spotter, a Weighted Alpha of 206.52+ and gained 254.95% in the last year
Read More

Brugler Ag Report

Today's Commentary

Corn futures are 1 to 2 cents lower this morning, with speculative attention drawn toward the beginning of bitcoin futures trading (+26% at one point overnight!). They saw gains of 1/4 to 1 1/4 cents on Friday, but nearby Dec was 1.38% for the week. ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.